{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:33:09Z","timestamp":1793320389434,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Sichuan Provincial Science and Technology Department","award":["2022NSFSC0827"],"award-info":[{"award-number":["2022NSFSC0827"]}]},{"DOI":"10.13039\/501100019971","name":"Luzhou Science and Technology Bureau","doi-asserted-by":"publisher","award":["2021CDLZ-9"],"award-info":[{"award-number":["2021CDLZ-9"]}],"id":[{"id":"10.13039\/501100019971","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Sichuan Science and Technology Program","award":["2022YFS0608"],"award-info":[{"award-number":["2022YFS0608"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s00259-025-07312-0","type":"journal-article","created":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T05:08:47Z","timestamp":1745989727000},"page":"4706-4716","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Clinical value of CXCR4-targeted PET-CT in primary aldosteronism: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-7902-2417","authenticated-orcid":false,"given":"Ranbie","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0135-1180","authenticated-orcid":false,"given":"Jingguang","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8204-1716","authenticated-orcid":false,"given":"Zhanwen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,30]]},"reference":[{"key":"7312_CR1","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/s2213-8587(17)30319-4","volume":"6","author":"S Monticone","year":"2018","unstructured":"Monticone S, D\u2019Ascenzo F, Moretti C, Williams TA, Veglio F, Gaita F, et al. Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 2018;6:41\u201350. https:\/\/doi.org\/10.1016\/s2213-8587(17)30319-4.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"7312_CR2","doi-asserted-by":"publisher","first-page":"10","DOI":"10.7326\/m20-0065","volume":"173","author":"JM Brown","year":"2020","unstructured":"Brown JM, Siddiqui M, Calhoun DA, Carey RM, Hopkins PN, Williams GH, et al. The unrecognized prevalence of primary aldosteronism: A Cross-sectional study. Ann Intern Med. 2020;173:10\u201320. https:\/\/doi.org\/10.7326\/m20-0065.","journal-title":"Ann Intern Med"},{"key":"7312_CR3","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1016\/j.jacc.2020.02.052","volume":"75","author":"Z Xu","year":"2020","unstructured":"Xu Z, Yang J, Hu J, Song Y, He W, Luo T, et al. Primary aldosteronism in patients in China with recently detected hypertension. J Am Coll Cardiol. 2020;75:1913\u201322. https:\/\/doi.org\/10.1016\/j.jacc.2020.02.052.","journal-title":"J Am Coll Cardiol"},{"key":"7312_CR4","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/s41574-022-00730-2","volume":"18","author":"AF Turcu","year":"2022","unstructured":"Turcu AF, Yang J, Vaidya A. Primary aldosteronism - a multidimensional syndrome. Nat Reviews Endocrinol. 2022;18:665\u201382. https:\/\/doi.org\/10.1038\/s41574-022-00730-2.","journal-title":"Nat Reviews Endocrinol"},{"key":"7312_CR5","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/s2213-8587(21)00210-2","volume":"9","author":"M Reincke","year":"2021","unstructured":"Reincke M, Bancos I, Mulatero P, Scholl UI, Stowasser M, Williams TA. Diagnosis and treatment of primary aldosteronism. Lancet Diabetes Endocrinol. 2021;9:876\u201392. https:\/\/doi.org\/10.1016\/s2213-8587(21)00210-2.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"7312_CR6","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1210\/jc.2015-4061","volume":"101","author":"JW Funder","year":"2016","unstructured":"Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016;101:1889\u2013916. https:\/\/doi.org\/10.1210\/jc.2015-4061.","journal-title":"J Clin Endocrinol Metab"},{"key":"7312_CR7","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1210\/jc.2008-2803","volume":"94","author":"N Sukor","year":"2009","unstructured":"Sukor N, Gordon RD, Ku YK, Jones M, Stowasser M. Role of unilateral adrenalectomy in bilateral primary aldosteronism: a 22-year single center experience. J Clin Endocrinol Metab. 2009;94:2437\u201345. https:\/\/doi.org\/10.1210\/jc.2008-2803.","journal-title":"J Clin Endocrinol Metab"},{"key":"7312_CR8","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/s2213-8587(22)00253-4","volume":"10","author":"TA Williams","year":"2022","unstructured":"Williams TA, Gong S, Tsurutani Y, Tezuka Y, Thuzar M, Burrello J, et al. Adrenal surgery for bilateral primary aldosteronism: an international retrospective cohort study. Lancet Diabetes Endocrinol. 2022;10:769\u201371. https:\/\/doi.org\/10.1016\/s2213-8587(22)00253-4.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"7312_CR9","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1007\/s00268-022-06780-x","volume":"47","author":"T Szabo Yamashita","year":"2023","unstructured":"Szabo Yamashita T, Shariq OA, Foster TR, Lyden ML, Dy BM, Young WF Jr., et al. Unilateral adrenalectomy for primary aldosteronism due to bilateral adrenal disease can result in resolution of hypokalemia and amelioration of hypertension. World J Surg. 2023;47:314\u20138. https:\/\/doi.org\/10.1007\/s00268-022-06780-x.","journal-title":"World J Surg"},{"key":"7312_CR10","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1148\/radiol.2015142159","volume":"278","author":"N Satani","year":"2016","unstructured":"Satani N, Ota H, Seiji K, Morimoto R, Kudo M, Iwakura Y, et al. Intra-adrenal aldosterone secretion: segmental adrenal venous sampling for localization. Radiology. 2016;278:265\u201374. https:\/\/doi.org\/10.1148\/radiol.2015142159.","journal-title":"Radiology"},{"key":"7312_CR11","doi-asserted-by":"publisher","unstructured":"Kitamoto T, Kitamoto KK, Omura M, Takiguchi T, Tsurutani Y, Kubo H, et al. Precise Mapping of Intra-Adrenal Aldosterone Activities Provides a Novel Surgical Strategy for Primary Aldosteronism. Hypertens. 2020;76:976\u2013\u200984. https:\/\/doi.org\/10.1161\/hypertensionaha.119.14341","DOI":"10.1161\/hypertensionaha.119.14341"},{"key":"7312_CR12","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1097\/hjh.0000000000003132","volume":"40","author":"TH Puar","year":"2022","unstructured":"Puar TH, Khoo CM, Tan CJ, Tong AKT, Tan MCS, Teo AE, et al. 11\u00a0C-Metomidate PET-CT versus adrenal vein sampling to subtype primary aldosteronism: a prospective clinical trial. J Hypertens. 2022;40:1179\u201388. https:\/\/doi.org\/10.1097\/hjh.0000000000003132.","journal-title":"J Hypertens"},{"key":"7312_CR13","doi-asserted-by":"publisher","first-page":"e2255609","DOI":"10.1001\/jamanetworkopen.2022.55609","volume":"6","author":"J Hu","year":"2023","unstructured":"Hu J, Xu T, Shen H, Song Y, Yang J, Zhang A, et al. Accuracy of Gallium-68 pentixafor positron emission tomography-Computed tomography for subtyping diagnosis of primary aldosteronism. JAMA Netw Open. 2023;6:e2255609. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.55609.","journal-title":"JAMA Netw Open"},{"key":"7312_CR14","doi-asserted-by":"publisher","unstructured":"Heinze B, Fuss CT, Mulatero P, Beuschlein F, Reincke M, Mustafa M, et al. Targeting CXCR4 (CXC Chemokine Receptor Type 4) for Molecular Imaging of Aldosterone-Producing Adenoma., Hypertens. 2018;71:317\u2013\u200925. https:\/\/doi.org\/10.1161\/hypertensionaha.117.09975","DOI":"10.1161\/hypertensionaha.117.09975"},{"key":"7312_CR15","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.1007\/s00259-020-04722-0","volume":"47","author":"J Ding","year":"2020","unstructured":"Ding J, Zhang Y, Wen J, Zhang H, Wang H, Luo Y, et al. Imaging CXCR4 expression in patients with suspected primary hyperaldosteronism. Eur J Nucl Med Mol Imaging. 2020;47:2656\u201365. https:\/\/doi.org\/10.1007\/s00259-020-04722-0.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7312_CR16","doi-asserted-by":"publisher","first-page":"812","DOI":"10.3760\/cma.j.cn112330-20220917-00510","volume":"43","author":"G Zheng","year":"2022","unstructured":"Zheng G, Ding J, Huo L, Tong A, Zhang Y, Li H, et al. Clinical application of (68)Ga-pentixafor PET\/CT in surgical diagnosis and prognosis evaluation of primary aldosteronism and correlation analysis of clinical prognosis. Chin J Urol. 2022;43:812\u20137. https:\/\/doi.org\/10.3760\/cma.j.cn112330-20220917-00510.","journal-title":"Chin J Urol"},{"key":"7312_CR17","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-024-04024-7","author":"R Zuo","year":"2024","unstructured":"Zuo R, Liu S, Ren X, Li W, Xia Z, Xu L, et al. Typing diagnostic value of (68)Ga-pentixafor PET\/CT for patients with primary aldosteronism and unilateral nodules. Endocrine. 2024. https:\/\/doi.org\/10.1007\/s12020-024-04024-7.","journal-title":"Endocrine"},{"key":"7312_CR18","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1001\/jama.2017.19163","volume":"319","author":"MDF McInnes","year":"2018","unstructured":"McInnes MDF, Moher D, Thombs BD, McGrath TA, Bossuyt PM, Clifford T, et al. Preferred reporting items for a systematic review and Meta-analysis of diagnostic test accuracy studies: the PRISMA-DTA statement. JAMA. 2018;319:388\u201396. https:\/\/doi.org\/10.1001\/jama.2017.19163.","journal-title":"JAMA"},{"key":"7312_CR19","doi-asserted-by":"publisher","first-page":"368","DOI":"10.2967\/jnumed.121.261964","volume":"63","author":"J Ding","year":"2022","unstructured":"Ding J, Tong A, Zhang Y, Wen J, Zhang H, Hacker M, et al. Functional characterization of adrenocortical masses in nononcologic patients using (68)Ga-Pentixafor. Journal of nuclear medicine: official publication. Soc Nuclear Med. 2022;63:368\u201375. https:\/\/doi.org\/10.2967\/jnumed.121.261964.","journal-title":"Soc Nuclear Med"},{"key":"7312_CR20","doi-asserted-by":"publisher","first-page":"1291775","DOI":"10.3389\/fendo.2024.1291775","volume":"15","author":"X Yin","year":"2024","unstructured":"Yin X, Ai K, Luo J, Liu W, Ma X, Zhou L, et al. A comparison of the performance of (68)Ga-Pentixafor PET\/CT versus adrenal vein sampling for subtype diagnosis in primary aldosteronism. Front Endocrinol. 2024;15:1291775. https:\/\/doi.org\/10.3389\/fendo.2024.1291775.","journal-title":"Front Endocrinol"},{"key":"7312_CR21","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13550-024-01125-2","volume":"14","author":"R Zuo","year":"2024","unstructured":"Zuo R, Liu S, Li W, Xia Z, Xu L, Pang H. Clinical value of (68)Ga-pentixafor PET\/CT in patients with primary aldosteronism and bilateral lesions: preliminary results of a single-centre study. EJNMMI Res. 2024;14:61. https:\/\/doi.org\/10.1186\/s13550-024-01125-2.","journal-title":"EJNMMI Res"},{"key":"7312_CR22","doi-asserted-by":"publisher","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","volume":"155","author":"PF Whiting","year":"2011","unstructured":"Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155:529\u201336. https:\/\/doi.org\/10.7326\/0003-4819-155-8-201110180-00009.","journal-title":"Ann Intern Med"},{"key":"7312_CR23","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ (Clinical Res ed). 2003;327:557\u201360. https:\/\/doi.org\/10.1136\/bmj.327.7414.557.","journal-title":"BMJ (Clinical Res ed)"},{"key":"7312_CR24","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.jclinepi.2005.01.016","volume":"58","author":"JJ Deeks","year":"2005","unstructured":"Deeks JJ, Macaskill P, Irwig L. The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol. 2005;58:882\u201393. https:\/\/doi.org\/10.1016\/j.jclinepi.2005.01.016.","journal-title":"J Clin Epidemiol"},{"key":"7312_CR25","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1148\/radiol.2015142779","volume":"277","author":"MD McInnes","year":"2015","unstructured":"McInnes MD, Bossuyt PM. Pitfalls of systematic reviews and Meta-Analyses in imaging research. Radiology. 2015;277:13\u201321. https:\/\/doi.org\/10.1148\/radiol.2015142779.","journal-title":"Radiology"},{"key":"7312_CR26","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1177\/09622802231172043","volume":"32","author":"J Shi","year":"2023","unstructured":"Shi J, Luo D, Wan X, Liu Y, Liu J, Bian Z, et al. Detecting the skewness of data from the five-number summary and its application in meta-analysis. Stat Methods Med Res. 2023;32:1338\u201360. https:\/\/doi.org\/10.1177\/09622802231172043.","journal-title":"Stat Methods Med Res"},{"key":"7312_CR27","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1177\/0962280216669183","volume":"27","author":"D Luo","year":"2018","unstructured":"Luo D, Wan X, Liu J, Tong T. Optimally estimating the sample mean from the sample size, median, mid-range, and\/or mid-quartile range. Stat Methods Med Res. 2018;27:1785\u2013805. https:\/\/doi.org\/10.1177\/0962280216669183.","journal-title":"Stat Methods Med Res"},{"key":"7312_CR28","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1471-2288-14-135","volume":"14","author":"X Wan","year":"2014","unstructured":"Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range. BMC Med Res Methodol. 2014;14:135. https:\/\/doi.org\/10.1186\/1471-2288-14-135.","journal-title":"BMC Med Res Methodol"},{"key":"7312_CR29","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1007\/s00330-022-09058-x","volume":"33","author":"Y Gao","year":"2022","unstructured":"Gao Y, Ding J, Cui Y, Li T, Sun H, Zhao D, et al. Functional nodules in primary aldosteronism: identification of CXCR4 expression with (68)Ga-pentixafor PET\/CT. Eur Radiol. 2022;33:996\u20131003. https:\/\/doi.org\/10.1007\/s00330-022-09058-x.","journal-title":"Eur Radiol"},{"key":"7312_CR30","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3760\/cma.j.cn112138-20220609-00440","volume":"62","author":"YJ Gao","year":"2023","unstructured":"Gao YJ, Ding J, Cui YY, Li TY, Zhang YS, Huo L, et al. Preliminary study on the ability of (68)Ga-Pentixafor PET\/CT to differentiate between adrenal aldosterone-producing adenoma and nonfunctional adenoma. Zhonghua Nei Ke Za Zhi. 2023;62:267\u201371. https:\/\/doi.org\/10.3760\/cma.j.cn112138-20220609-00440.","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"7312_CR31","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1210\/clinem\/dgad421","volume":"109","author":"Y Zheng","year":"2023","unstructured":"Zheng Y, Long T, Peng N, Zhen M, Ye Q, Zhang Z, et al. The value of targeting CXCR4 with 68Ga-Pentixafor PET\/CT for subtyping primary aldosteronism. J Clin Endocrinol Metab. 2023;109:171\u201382. https:\/\/doi.org\/10.1210\/clinem\/dgad421.","journal-title":"J Clin Endocrinol Metab"},{"key":"7312_CR32","doi-asserted-by":"publisher","first-page":"117","DOI":"10.2967\/jnumed.123.266061","volume":"65","author":"J Ding","year":"2024","unstructured":"Ding J, Li X, Liu S, Gao Y, Zheng G, Hacker M, et al. Clinical value of (68)Ga-Pentixafor PET\/CT in subtype diagnosis of primary aldosteronism patients with adrenal micronodules. Journal of nuclear medicine: official publication. Soc Nuclear Med. 2024;65:117\u201324. https:\/\/doi.org\/10.2967\/jnumed.123.266061.","journal-title":"Soc Nuclear Med"},{"key":"7312_CR33","doi-asserted-by":"publisher","first-page":"7281","DOI":"10.7150\/thno.100848","volume":"14","author":"L He","year":"2024","unstructured":"He L, Yang Y, Cao X, Zhu X, Liu N, Chen X, et al. [18F]AlF-NOTA-pentixather PET\/CT of CXCR4 in patients with suspected primary hyperaldosteronism. Theranostics. 2024;14:7281\u201391. https:\/\/doi.org\/10.7150\/thno.100848.","journal-title":"Theranostics"},{"key":"7312_CR34","doi-asserted-by":"publisher","first-page":"500","DOI":"10.13406\/j.cnki.cyxb.003477","volume":"49","author":"C Xu","year":"2024","unstructured":"Xu C, Zhou F, Huang Y, Zhang Y. Application value of PET\/CT in functional localization diagnosis of primary aldosteronism. Jounral Chongqing Med Univ. 2024;49:500\u20136. https:\/\/doi.org\/10.13406\/j.cnki.cyxb.003477.","journal-title":"Jounral Chongqing Med Univ"},{"key":"7312_CR35","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgae747","author":"X Zhang","year":"2024","unstructured":"Zhang X, Song Y, Jing Y, Hu J, Shen H, Zhang A, et al. Comparison of different diagnostic criteria of 68Ga-Pentixafor PET\/CT for the classification of primary aldosteronism. J Clin Endocrinol Metab. 2024. https:\/\/doi.org\/10.1210\/clinem\/dgae747.","journal-title":"J Clin Endocrinol Metab"},{"key":"7312_CR36","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/s2213-8587(17)30135-3","volume":"5","author":"TA Williams","year":"2017","unstructured":"Williams TA, Lenders JWM, Mulatero P, Burrello J, Rottenkolber M, Adolf C, et al. Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort. Lancet Diabetes Endocrinol. 2017;5:689\u201399. https:\/\/doi.org\/10.1016\/s2213-8587(17)30135-3.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"7312_CR37","doi-asserted-by":"publisher","first-page":"e572","DOI":"10.1097\/rlu.0000000000004202","volume":"47","author":"Q Shu","year":"2022","unstructured":"Shu Q, Deng M, Chen Y, Liu N, Cai L. Imaging Aldosterone-Producing adrenocortical carcinoma with 68 Ga-Pentixafor PET\/CT. Clin Nucl Med. 2022;47:e572\u20133. https:\/\/doi.org\/10.1097\/rlu.0000000000004202.","journal-title":"Clin Nucl Med"},{"key":"7312_CR38","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1161\/hypertensionaha.109.146613","volume":"55","author":"P Mulatero","year":"2010","unstructured":"Mulatero P, Bertello C, Sukor N, Gordon R, Rossato D, Daunt N, et al. Impact of different diagnostic criteria during adrenal vein sampling on reproducibility of subtype diagnosis in patients with primary aldosteronism. Hypertens (Dallas Tex: 1979). 2010;55:667\u201373. https:\/\/doi.org\/10.1161\/hypertensionaha.109.146613.","journal-title":"Hypertens (Dallas Tex: 1979)"},{"key":"7312_CR39","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s42155-021-00220-y","volume":"4","author":"KB Quencer","year":"2021","unstructured":"Quencer KB. Adrenal vein sampling: technique and protocol, a systematic review. CVIR Endovascular. 2021;4:38. https:\/\/doi.org\/10.1186\/s42155-021-00220-y.","journal-title":"CVIR Endovascular"},{"key":"7312_CR40","doi-asserted-by":"publisher","unstructured":"Chinese_Society_of_Endocrinology. Expert consensus on the diagnosis and treatment of primary aldosteronism. (2020). Chinese Journal of Endocrinology and Metabolism. 2020;36:727\u2013\u200936. https:\/\/doi.org\/10.3760\/cma.j.cn311282-20200615-00444","DOI":"10.3760\/cma.j.cn311282-20200615-00444"},{"key":"7312_CR41","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1097\/hjh.0000000000002510","volume":"38","author":"P Mulatero","year":"2020","unstructured":"Mulatero P, Monticone S, Deinum J, Amar L, Prejbisz A, Zennaro MC, et al. Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the working group on endocrine hypertension of the European society of hypertension. J Hypertens. 2020;38:1919\u201328. https:\/\/doi.org\/10.1097\/hjh.0000000000002510.","journal-title":"J Hypertens"},{"key":"7312_CR42","doi-asserted-by":"publisher","unstructured":"Rossi GP, Auchus RJ, Brown M, Lenders JW, Naruse M, Plouin PF et al. An expert consensus statement on use of adrenal vein sampling for the subtyping of primary aldosteronism. Hypertens. 2014;63:151\u2013\u200960. https:\/\/doi.org\/10.1161\/hypertensionaha.113.02097","DOI":"10.1161\/hypertensionaha.113.02097"},{"key":"7312_CR43","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1097\/rlu.0000000000003503","volume":"46","author":"J Ding","year":"2021","unstructured":"Ding J, Tong A, Zhang Y, Zhang H, Huo L. Cortisol-Producing adrenal adenomas with intense activity on 68Ga-Pentixafor PET\/CT. Clin Nucl Med. 2021;46:350\u20132. https:\/\/doi.org\/10.1097\/rlu.0000000000003503.","journal-title":"Clin Nucl Med"},{"key":"7312_CR44","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1097\/rlu.0000000000004244","volume":"47","author":"J Ding","year":"2022","unstructured":"Ding J, Tong A, Hacker M, Feng M, Huo L, Li X. Usefulness of 68 Ga-Pentixafor PET\/CT on diagnosis and management of Cushing syndrome. Clin Nucl Med. 2022;47:669\u201376. https:\/\/doi.org\/10.1097\/rlu.0000000000004244.","journal-title":"Clin Nucl Med"},{"key":"7312_CR45","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1007\/s12020-024-03865-6","volume":"85","author":"X Wei","year":"2024","unstructured":"Wei X, Wu F, Dong H, Jing Y, Song Y, Pang H, et al. (68)Ga-pentixafor PET\/CT in the localization diagnosis of primary aldosteronism concurrent subclinical Cushing\u2019s syndrsome: two case reports. Endocrine. 2024;85:1398\u2013406. https:\/\/doi.org\/10.1007\/s12020-024-03865-6.","journal-title":"Endocrine"},{"key":"7312_CR46","doi-asserted-by":"publisher","first-page":"e233469","DOI":"10.1148\/radiol.233469","volume":"313","author":"Y Wu","year":"2024","unstructured":"Wu Y, Wu Y, Yao B, Ren S, Wu S, Rui W, et al. Diagnostic accuracy and value of CXCR4-targeted PET\/MRI using (68)Ga-Pentixafor for tumor localization in Cushing disease. Radiology. 2024;313:e233469. https:\/\/doi.org\/10.1148\/radiol.233469.","journal-title":"Radiology"},{"key":"7312_CR47","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1291\/hypres.29.883","volume":"29","author":"M Omura","year":"2006","unstructured":"Omura M, Sasano H, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T. Clinical characteristics of aldosterone-producing microadenoma, macroadenoma, and idiopathic hyperaldosteronism in 93 patients with primary aldosteronism. Hypertens Research: Official J Japanese Soc Hypertens. 2006;29:883\u20139. https:\/\/doi.org\/10.1291\/hypres.29.883.","journal-title":"Hypertens Research: Official J Japanese Soc Hypertens"},{"key":"7312_CR48","doi-asserted-by":"publisher","unstructured":"Baba S, Miyoshi A, Obara S, Usubuchi H, Terae S, Sunahara M et al. A case of Williams syndrome with suspected coexisting ectopic aldosterone-producing tumor in the liver. Endocrinol. diabetes metab. case rep. 2020;2020. https:\/\/doi.org\/10.1530\/edm-20-0057","DOI":"10.1530\/edm-20-0057"},{"key":"7312_CR49","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s12022-022-09710-8","volume":"33","author":"O Mete","year":"2022","unstructured":"Mete O, Erickson LA, Juhlin CC, de Krijger RR, Sasano H, Volante M, et al. Overview of the 2022 WHO classification of adrenal cortical tumors. Endocr Pathol. 2022;33:155\u201396. https:\/\/doi.org\/10.1007\/s12022-022-09710-8.","journal-title":"Endocr Pathol"},{"key":"7312_CR50","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3760\/cma.j.cn311282-20241115-00546","volume":"41","author":"Chinese_Society_of_Endocrinology","year":"2025","unstructured":"Chinese_Society_of_Endocrinology. Expert consensus on the diagnosis and treatment of primary aldosteronism(2024). Chin J Endocrinol Metabolism. 2025;41:12\u201324. https:\/\/doi.org\/10.3760\/cma.j.cn311282-20241115-00546.","journal-title":"Chin J Endocrinol Metabolism"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07312-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-025-07312-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07312-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T08:36:36Z","timestamp":1759394196000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-025-07312-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,30]]},"references-count":50,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["7312"],"URL":"https:\/\/doi.org\/10.1007\/s00259-025-07312-0","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,30]]},"assertion":[{"value":"5 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This is a systematic review and meta-analysis, and the ethics committee has confirmed that ethical approval is not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}